ribociclib
novartis
['breast', ' ribo', 'ribociclib']
the combination of ribociclib and endocrine therapy has already been shown to yield a significant survival advantage for women with metastatic, hr+/her2- breast cancer. #asco23 #medicalnews 
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.